Recent study has demonstrated that CCT has a critical role in mammalian target of rapamycin (mTOR) complex assembly and signaling, which are master regulator autophagy contributing highly to drug resistance in AML [5]. The gene discussed is MTOR; the disease is acute myeloid leukemia.